Form 8-K - Current report:
SEC Accession No. 0001558370-20-003927
Filing Date
2020-04-15
Accepted
2020-04-15 17:13:46
Documents
6
Period of Report
2020-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20200413x8k.htm 8-K 47033
2 EX-4.1 nrbo-20200413xex4d1.htm EX-4.1 145698
3 EX-5.1 nrbo-20200413xex5d1.htm EX-5.1 13504
4 EX-10.1 nrbo-20200413xex10d1.htm EX-10.1 267183
5 EX-99.1 nrbo-20200413xex99d1.htm EX-99.1 11558
6 GRAPHIC nrbo-20200413xex99d1g001.jpg GRAPHIC 25387
  Complete submission text file 0001558370-20-003927.txt   521437
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 20794404
SIC: 2834 Pharmaceutical Preparations